Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis-Reference-Cited by-同舟云学术

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis

Published:2022-07-10 Issue:12 Volume:88 Page:5227-5237
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Hlavaty Alex¹,Roustit Matthieu²³^ORCID,Montani David⁴⁵⁶^ORCID,Chaumais Marie‐Camille⁴⁷⁸,Guignabert Christophe⁴⁵,Humbert Marc⁴⁵⁶,Cracowski Jean‐Luc¹³,Khouri Charles¹²³^ORCID

Affiliation:

1. Pharmacovigilance Unit Grenoble Alpes University Hospital Grenoble France

2. Clinical Pharmacology Department INSERM CIC1406 Grenoble Alpes University Hospital Grenoble France

3. HP2 Laboratory, Inserm U1300 Grenoble Alpes University ‐ Grenoble France

4. INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue Le Plessis‐Robinson France

5. Faculté de Médecine Université Paris‐Saclay Le Kremlin‐Bicêtre France

6. Assistance Publique ‐ Hôpitaux de Paris (AP‐HP), Service de Pneumologie, Centre de référence Maladie Rares de l'Hypertension Pulmonaire Hôpital Bicêtre Le Kremlin‐Bicêtre France

7. Faculté de Pharmacie Université Paris‐Saclay Châtenay Malabry France

8. Assistance Publique ‐ Hôpitaux de Paris (AP‐HP), Service de Pharmacie Hôpital Bicêtre Le Kremlin‐Bicêtre France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15436

Reference45 articles.

1. Epidemiologic studies on the relation between use of appetite depressants and primary vascular pulmonary hypertension;Greiser E;Internist,1973

2. Drug-associated pulmonary arterial hypertension

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database;Journal of Affective Disorders;2024-04

2. Angiogenesis Redux: An Overall Protective Role of VEGF/KDR Signaling in the Microvasculature in Pulmonary Arterial Hypertension;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-10

3. Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study;Drug Safety;2023-07-08

4. An interesting case of pulmonary hypertension in nephrotic syndrome due to amphetamine use for ADHD;Annals of Medicine & Surgery;2023-04-04

5. Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies;Frontiers in Oncology;2023-02-06